Vacci-Test Demonstrates The First Same-Shift Test For E.coli O157:H7

Main Category: Nutrition / Diet
Also Included In: Infectious Diseases / Bacteria / Viruses;  Medical Devices / Diagnostics
Article Date: 27 Aug 2008 - 3:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

With food safety top of mind for consumers and the food industry, Vacci-Test Corporation ("Vacci-Test") is pleased to announce that its first food safety test, FoodChek(TM)-E.coli, has successfully completed a field trial at a major meat packaging facility and has shown that it can accurately test for E.coli O157:H7 in less than 6 hours, including enrichment. FoodChek(TM)-E.coli is a revolutionary new same-shift test that is rapid, accurate and cost effective. FoodChek(TM)-E.coli is a breakthrough solution for meat-processors enabling them to deliver high quality and safe products to consumers.

FoodChek(TM)-E.coli uses magnetic nanotechnology and a proprietary, inexpensive and easy-to-use magnetic reader that provides a very sensitive, specific and quantitative test result.

The field trial was conducted at Vantage Foods Inc., a leading processor of retail ready fresh meats, at their facility in Chilliwack, British Columbia. Mr. Gary Haley, President and CEO of Vantage Foods stated "We are pleased to have been able to work with Vacci-Test in field testing their new rapid E.coli product. Vantage Foods prides itself on using leading edge technology such as FoodChek(TM)-E.coli to compliment our best business practices philosophy of distributing the highest quality and safest products to our customers."

Sandy MacPherson, Chairman of the Executive Operating Committee of Vacci-Test, stated "Our FoodChek(TM)-E.coli test will have a major impact for both regulatory agencies and meat-processors. Potential food contaminants such as E.coli O157:H7 can now be tested on site and identified prior to the end of a production shift. FoodChek(TM)-E.coli eliminates the need for slaughterhouses and meat-processors to hold finished products in cold storage until testing can be completed by off-site third parties."

Vacci-Test is a privately held Canadian corporation that specializes in the development and commercialization of proprietary food safety tests, based on magnetic nanotechnology, for the rapid detection and quantitative measurement of pathogens in food. Vacci-Test's product pipeline includes a series of additional tests such as Listeria and Salmonella for the burgeoning food safety market.

This information release may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its private filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Vacci-Test Corporation